Yoshida, Takahiro Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Goto, Masakazu Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Inoue, Seiya Tokushima University Tokushima University Educator and Researcher Directory
Minato, Takuya Tokushima University
Fujiwara, Satoshi Tokushima University Tokushima University Educator and Researcher Directory
Furukita, Yoshihito Tokushima University
Yuasa, Yasuhiro Tokushima University
Yamai, Hiromichi Tokushima University
Toba, Hiroaki Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Takizawa, Hiromitsu Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Yoshida, Mitsuteru Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Seike, Junichi Tokushima University
Miyoshi, Takanori Tokushima University
Tangoku, Akira Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Daikenchuto (TJ-100), a traditional Japanese herbal medicine, is widely used in Japan. Its effects on gastrointestinal motility and microcirculation and its anti-inflammatory effect are known. The purpose of this prospective randomized controlled trial was to investigate the effect of TJ-100 after esophagectomy in esophageal cancer patients.
Forty patients for whom subtotal esophageal resection for esophageal cancer was planned at our institute from March 2011 to August 2013 were enrolled and divided into two groups at the point of determination of the operation schedule after informed consent was obtained: a TJ-100 (15 g/day)-treated group (n = 20) and a control group (n = 20). The primary efficacy end-points were maintenance of the nutrition condition and the recovery of gastrointestinal function. The secondary efficacy end-points were the serum C-reactive protein (CRP) level and adrenomedullin level during the postoperative course, the incidence of postoperative complications, and the length of hospital stay after surgery.
We examined 39 patients because one patient in the TJ-100 group was judged as having unresectable cancer after surgery. The mean age of the TJ-100 group patients was significantly older than that of the control group patients.The rate of body weight decrease at postoperative day 21 was significantly suppressed in the TJ-100 group (3.6% vs. the control group: 7.0%, p = 0.014), but the serum albumin level was not significantly different between the groups. The recovery of gastrointestinal function regarding flatus, defecation, and oral intake showed no significant between-group differences, but postoperative bowel symptoms tended to be rare in the TJ-100 group. There was no significant between-group difference in the length of hospital stay after surgery. The serum CRP level at postoperative day 3 was 4.9 mg/dl in the TJ-100 group and 6.9 mg/dl in the control group, showing a tendency of a suppressed serum CRP level in the TJ-100 group (p = 0.126). The rate of increase in adrenomedullin tended to be high postoperatively, but there was no significant difference between the two groups.
TJ-100 treatment after esophageal cancer resection has the effects of prompting the recovery of gastrointestinal motility and minimizing body weight loss, and it might suppress the excess inflammatory reaction related to surgery.
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
|DOI (Published Version)|
|URL ( Publisher's Version )|
esoph_15_2_75.pdf 761 KB